InspireMD, Inc. NSPR recently announced the official commercial launch of the CGuard Prime Carotid Stent System in the United ...

A series of neutral trials on anticoagulation in embolic stroke of undetermined source (ESUS) has moved the needle scientifically but left physicians with questions about secondary prevention and ...

BOSTON, MA—Those who were hoping that PROTECTED TAVR would provide a clear-cut result and bring closure to the question of whether cerebral embolic protection (CEP) reduces stroke in patients ...

To address this, a device—called an embolic protection device—was developed to prevent a stroke by putting filters in the blood vessels that go to the brain.

In this randomized trial, the use of cerebral embolic protection (CEP) did not decrease the 72-hour incidence of stroke in ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in ...

Thrombotic strokes. They're caused by a blood clot that forms in an artery that supplies blood to your brain, also called an atherosclerotic stroke. Embolic strokes.

Hemorrhagic stroke Hemorrhagic strokes, which make up about 13 percent of stroke cases, occur when a weak blood vessel ruptures, causing bleeding into the surrounding brain tissue.

Cerebral embolic protection devices are designed to capture embolic material that enters the bloodstream during TAVR, preventing it from reaching the brain and causing a stroke.

Dr. Mohammad Anadani shared some intriguing theories on what’s behind the alarming trend of healthy 20-somethings having strokes.